Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drug
<p>Abstract</p> <p>Background</p> <p><it>N</it>-(6-(4-chlorophenoxy)hexyl)-<it>N</it>'-cyano-<it>N''</it>-4-pyridyl guanidine) (CHS 828) is the first candidate drug from a novel group of anti-tumour agents – the pyridyl...
Main Authors: | Gullbo Joachim, Burman Robert, Lövborg Henrik |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-06-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/2/114 |
Similar Items
-
Cellular Pharmacology of the Novel Antitumoural Cyanoguanidine CHS 828
by: Lövborg, Henrik
Published: (2004) -
Microphysiometry in the evaluation of cytotoxic drugs with special emphasis on the novel cyanoguanidine CHS 828
by: Ekelund, Sara
Published: (2001) -
Methods for Preclinical Evaluation of Cytotoxic Drugs : With Special Reference to the Cyanoguanidine CHS 828 and Hollow Fiber Method
by: Hassan, Saadia Bashir
Published: (2004) -
Preclinical and Clinical Development of the Novel Cyanoguanidine CHS 828 for Cancer Treatment
by: Hovstadius, Peter
Published: (2005) -
Pharmacological Studies of CHS 828 and Etoposide Induced Tumour Cell Death
by: Martinsson, Petra
Published: (2001)